OptimizeRx Corp (OPRX)
14.64
+0.14
(+0.97%)
USD |
NASDAQ |
Mar 31, 16:00
14.65
+0.01
(+0.07%)
After-Hours: 20:00
Key Stats
Price and Performance | |
---|---|
Market Cap | 250.35M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -61.18% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 4.169 |
Price to Book Value | 1.985 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.00 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 87.20% |
News
Headline
Wire
Time (ET)
Globe Newswire
03/29 09:20
Yahoo
03/12 08:40
Analysts Have Lowered Expectations For OptimizeRx Corporation (NASDAQ:OPRX) After Its Latest Results
Yahoo
03/11 07:13
MT Newswires
03/09 11:15
Events
DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
05/04/2023* | 16:30 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
05/04/2023* | -- | Results | Q1 2023 | -- | -0.07 | -- | |
03/08/2023 | 16:30 EST | Earnings Call | Q4 2022 | -- | -- | -- | |
03/08/2023 | -- | Results | Q4 2022 | 0.25 | 0.24 | 3.55% | |
11/08/2022 | 16:30 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
11/08/2022 | -- | Results | Q3 2022 | 0.07 | 0.04 | 88.48% | |
08/09/2022 | 16:30 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
08/09/2022 | -- | Results | Q2 2022 | 0.04 | 0.09 | -55.56% |
*Estimated Date/Time
Earnings
Profile
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement. |
URL | https://www.optimizerx.com |
Investor Relations URL | https://investors.optimizerx.com/ |
HQ State/Province | Michigan |
Sector | Healthcare |
Industry | Health Information Services |
Equity Style | Small Cap/Growth |
Next Earnings Release | May. 04, 2023 (est.) |
Last Earnings Release | Mar. 08, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Analyst Coverage
Consensus Rating
|
|
Analyst Recommendation
|
Source: S&P Global
Dividends
Dividend Per Share (TTM) | -- |
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
Yield to Market | 0.00 |
Yield to Sector | 0.00 |
Yield to Industry | 0.00 |
Last Dividend Amt. | -- |
Dividend Frequency | -- |
Last Ex-Dividend Date | -- |
Yield (TTM) | 0.00% |
Forward Yield | -- |
Payout Ratio | 0.00% |
Cash Payout Ratio | 0.00% |
Consistent Payer (5Y) | No |
Consistent Growth (5Y) | No |
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 31, 2023.
Fundamentals
Revenue (TTM) | 62.45M |
Total Expenses (TTM) | 74.74M |
Net Income (TTM) | -11.44M |
Total Assets (Quarterly) | 134.65M |
Total Liabilities (Quarterly) | 8.540M |
Shareholders Equity (Quarterly) | 126.11M |
Cash from Operations (TTM) | 10.65M |
Cash from Investing (TTM) | -58.18M |
Cash from Financing (TTM) | -18.95M |
Ratings
Profile
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement. |
URL | https://www.optimizerx.com |
Investor Relations URL | https://investors.optimizerx.com/ |
HQ State/Province | Michigan |
Sector | Healthcare |
Industry | Health Information Services |
Equity Style | Small Cap/Growth |
Next Earnings Release | May. 04, 2023 (est.) |
Last Earnings Release | Mar. 08, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ownership
Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
Consensus Rating
|
|
Analyst Recommendation
|
Source: S&P Global
Other Resources
Whale Wisdom | 13F Filings |
Seeking Alpha | Call Transcripts |
Nasdaq | Insider Trading |
Nasdaq | Institutional Ownership |
Nasdaq | Option Chain |
SEC | SEC Filings |
OPRX Tweets |